TrialCancer medicine2021

Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials.

Renata Ferrarotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.